End-to-End Clinical Trial & CRO Services in Greece
Advancing Life Sciences Excellence Through Strategic GxP Compliance Solutions
Greece is becoming a key hub for clinical research, pharmaceutical development, and healthcare innovation in Southeast Europe, facilitated by a robust healthcare system and experienced research institutions. The National Organization for Medicines (EOF) regulates medicinal products and clinical research activities under EU and EMA guidelines, adhering to ICH standards and GCP principles, ensuring compliance with the EU Clinical Trials Regulation (EU CTR 536/2014).
Greece is enhancing its role as a clinical research hub by promoting innovation and collaboration among various stakeholders. Its skilled workforce and adherence to European regulatory standards facilitate efficient product development. Zenovel provides specialized GxP compliance and regulatory support services for pharmaceutical and healthcare entities in Greece, helping them meet evolving regulations and maintain quality standards throughout the product lifecycle.
Good Clinical Practice (GCP) Services in Greece for Clinical Research Compliance
Supporting High-Quality Clinical Research Through GCP Excellence
Greece is emerging as a prominent clinical research hub in Europe, bolstered by skilled investigators and academic medical centers, with a regulatory framework that adheres to European standards. Clinical trials are overseen by the National Organization for Medicines (EOF), aligning with ICH-GCP guidelines and EU Clinical Trials Regulation (EU CTR 536/2014). Zenovel offers customized GCP services to ensure regulatory compliance, participant safety, data integrity, and overall quality in the clinical trial process.
Our GCP Services in Greece Include:
- GCP Quality & Compliance Consulting – Strengthening quality systems and optimizing clinical trial processes.
- Regulatory Compliance Support – Guidance on ICH-GCP, EU CTR 536/2014, EOF requirements, and ethics compliance.
- Inspection Readiness & Quality Assurance – Mock inspections, gap assessments, documentation reviews, and CAPA support.
- Sponsor Oversight & Vendor Management – Establishing effective oversight of CROs, vendors, and clinical sites.
- Risk-Based Quality Management – Implementing risk-based monitoring and quality strategies to protect participant safety and data quality.
Zenovel provides organizations in Greece with risk-based GCP solutions that improve compliance and inspection readiness, facilitating the successful execution of clinical research in line with European and international regulations.
Computer System Validation (CSV) Services in Greece for GxP & Data Integrity Compliance
Ensuring Compliant, Reliable, and Inspection-Ready Computerized Systems
As Greece enhances its presence in clinical research and pharmaceutical development, validated computerized systems are crucial for maintaining data integrity, patient safety, and regulatory compliance. Zenovel offers risk-based Computer System Validation (CSV) services to pharmaceutical firms, CROs, biotechnology companies, and healthcare organizations, ensuring compliance throughout the system lifecycle, in alignment with GAMP 5, ICH-GCP, EU Annex 11, EU GMP, and relevant international GxP standards.
Our CSV Services in Greece Include:
- Validation Strategy & Planning – Development of validation master plans, validation strategies, and compliance roadmaps.
- Requirements & Traceability Management – Review of URS, functional specifications, and traceability matrices.
- Risk Assessment & System Classification – Identification of critical functions, compliance risks, and validation priorities.
- IQ/OQ/PQ Support – Execution and documentation of installation, operational, and performance qualification activities.
- Data Integrity Reviews – Assessment of audit trails, user access controls, data governance, and record management practices.
- Electronic Records & e-Signature Compliance – Support for compliance with EU Annex 11 and 21 CFR Part 11 requirements.
- Change Control & Lifecycle Management – Ongoing support for system changes, upgrades, periodic reviews, and retirement activities.
- Validation Documentation Support – Preparation and review of protocols, reports, SOPs, and validation packages
Zenovel assists organizations in creating and sustaining validated computerized environments that ensure regulatory compliance and reliable data. We collaborate with stakeholders to mitigate compliance risks, enhance data integrity, and meet GxP standards.
GCP Audit Services in Greece for Clinical Research Compliance
Strengthening Clinical Trial Quality Through Independent GCP Audits
Maintaining robust quality oversight is crucial for protecting study participants and ensuring data integrity. Zenovel offers independent GCP audit services in Greece to assist sponsors, CROs, investigator sites, and vendors in compliance and operational excellence. Audits adhere to ICH E6(R3) Good Clinical Practice guidelines, the EU Clinical Trials Regulation (EU CTR 536/2014), and the National Organization for Medicines (EOF) regulations.
Our GCP Audit Services in Greece Include:
- Clinical Site Audits – Evaluation of protocol compliance, informed consent, participant safety, source documentation, and site operations.
- Sponsor & CRO Audits – Assessment of quality systems, governance structures, oversight activities, and operational processes.
- Vendor Audits – Review of laboratories, technology providers, and third-party service partners supporting clinical trials.
- QMS Assessments – Evaluation of SOPs, training programs, deviation management, and quality governance frameworks.
- Regulatory Compliance Reviews – Assessment of compliance with ICH-GCP, EU CTR 536/2014, and international clinical research standards.
- Data Integrity & Critical Process Audits – Review of essential documents, source data, protocol adherence, and participant protection measures.
- CAPA & Inspection Readiness Support – Assistance with remediation planning, CAPA implementation, and inspection preparedness.
Zenovel’s auditors deliver risk-based assessments and actionable recommendations to enhance quality systems, mitigate compliance risks, improve oversight, and ensure inspection readiness in the clinical trial lifecycle.
CRO Setup & Upgradation Services in Greece for GCP and Regulatory Compliance
Building Inspection-Ready CRO Operations for Sustainable Clinical Research Growth
Greece is gaining recognition as a desirable location for clinical research, bolstered by skilled investigators, robust research institutions, and a regulatory framework in line with European standards. Establishing or improving a Contract Research Organization (CRO) necessitates strong quality systems, effective governance, and regulatory compliance. Zenovel offers CRO setup and upgradation services, aiding organizations in developing scalable, efficient, and inspection-ready operations that meet EOF requirements, EU regulations, and ICH-GCP guidelines.
New CRO Setup Services in Greece
Our end-to-end CRO establishment solutions include:
- Clinical Operations & Organizational Design
- Quality Management System (QMS) Development
- SOP Development & Documentation Frameworks
- Clinical Technology & System Implementation
- Risk-Based Monitoring & Quality Oversight
- Vendor Qualification & Governance Programs
- Clinical Quality & Compliance Frameworks
- Data Integrity & Regulatory Compliance Systems
- Workforce Training & Capability Development
Existing CRO Upgradation Services in Greece
For organizations seeking enhanced performance and compliance, we offer:
- GCP Gap Assessments & Remediation
- Quality System Modernization
- Sponsor Oversight Enhancement
- Risk-Based Quality Management Implementation
- Clinical Monitoring Optimization
- Vendor Management Improvements
- CAPA System Strengthening
- Inspection Readiness Programs
- Data Integrity & Computerized System Compliance
- Regulatory Alignment & Operational Excellence
Zenovel aids CROs in creating strong quality frameworks, enhancing operational efficiency, ensuring compliance oversight, and achieving inspection readiness, thereby supporting sustainable growth and successful clinical trials as per European and international standards.
PK-Stat Review Services in Greece for Reliable Clinical Data Evaluation
Ensuring Robust Pharmacokinetic and Statistical Evaluation for Regulatory Success
Accurate pharmacokinetic and statistical analysis is vital for producing reliable clinical evidence and aiding regulatory submissions. Zenovel offers PK-Stat Review Services in Greece for pharmaceutical, biotechnology, and healthcare organizations, ensuring high-quality evaluation of clinical data throughout drug development. Our services promote data integrity, regulatory alignment, and scientific robustness in line with EU regulatory expectations and international guidelines.
Our PK-Stat Review Services in Greece include the following:
- PK/PD Analysis—Non-compartmental analysis (NCA), population PK modeling, exposure-response evaluation, and dose-response analysis.
- Regulatory Alignment – Compliance with EOF requirements, EMA expectations, ICH guidelines, and other international regulatory standards.
- Data Integrity & Statistical Review – Clinical biostatistics review, statistical validation, data quality assessment, and submission-ready outputs.
- Regulatory Submission Support—Independent review for bioequivalence studies, clinical trials, marketing authorization applications, and life cycle submissions.
Zenovel provides PK analysis services, including bioavailability assessment, dose proportionality evaluation, PK/PD interpretation, population modeling, and statistical reporting that comply with global regulatory standards. Our services aim to enhance data quality, minimize regulatory risks, and boost confidence in clinical decision-making, particularly in Greece, Europe, and global markets.
Pre-Inspection Readiness Services in Greece for GCP Compliance
Building Inspection Confidence Through Proactive GCP Readiness
Regulatory inspections are essential for assessing clinical trial quality and compliance. Zenovel offers Pre-Inspection Readiness Services in Greece, assisting sponsors and CROs in enhancing inspection preparedness and identifying compliance gaps.
Our risk-based approach aligns with EU regulations, focusing on documentation, processes, and oversight to ensure readiness. Zenovel conducts structured assessments and mock inspections based on GCP standards, enabling organizations to proactively address deficiencies before actual inspections.
Clinical Trial Documentation & Quality System Reviews: Evaluation of TMF, informed consent, protocol compliance, safety reporting, data integrity, vendor oversight, and quality management systems is crucial for ensuring inspection readiness and regulatory alignment.
CAPA Evaluation & Remediation Planning: Evaluation of CAPA systems focusing on root cause analysis, effectiveness, sustainability, regulatory adequacy, and implementation of corrective actions to address compliance gaps.
Sponsor Oversight & Vendor Management Reviews: Effective trial control and compliance are achieved through governance frameworks, CRO oversight models, vendor qualification processes, risk management systems, and performance monitoring.
Inspection Preparedness Training: Targeted training for clinical teams focuses on inspection readiness strategies, regulatory interactions, documentation retrieval, and interview preparation to ensure successful inspection outcomes.
Zenovel’s services comply with EOF, ICH E6(R3) GCP guidelines, EU CTR 536/2014, EMA expectations, and international standards. Our inspection readiness experts assist sponsors and CROs in enhancing compliance frameworks, operational quality, and inspection outcomes through a structured approach that addresses compliance gaps and fosters long-term confidence in clinical development programs.
Risk-Based Monitoring (RBM) Services in Greece for Efficient Clinical Trials
Improving Clinical Trial Quality Through Proactive Risk-Based Monitoring
Effective clinical trial oversight is essential for ensuring participant safety, data integrity, and regulatory compliance. Zenovel provides Risk-Based Monitoring (RBM) Services in Greece to help sponsors and CROs optimize trial performance, improve operational efficiency, and strengthen study oversight through a proactive, data-driven approach.
Our RBM solutions are aligned with ICH E6(R3) Good Clinical Practice guidelines, EU Clinical Trials Regulation (EU CTR 536/2014), and applicable European regulatory requirements.
Zenovel’s RBM Services in Greece Include the Following:
- Proactive Risk Identification & Assessment – Early detection and evaluation of critical study risks using risk-based methodologies.
- Centralized & Remote Monitoring – Ongoing remote review of clinical and operational data to support efficient trial oversight.
- GCP-Compliant Monitoring Strategies – Development and implementation of risk-based monitoring plans that strengthen sponsor oversight.
- Real-Time Data Review & Site Performance Assessment – Continuous evaluation of data quality, protocol compliance, recruitment metrics, and site performance indicators.
Our experts assist organizations in detecting deviations early and enhancing monitoring of vital data and processes. Zenovel integrates risk-based quality management into clinical operations, promoting efficient and inspection-ready clinical trials globally, including in Greece and Europe, while ensuring regulatory compliance.
Sponsor Oversight Services in Greece for Clinical Trial Governance and Compliance
Strengthening Clinical Trial Oversight Through Effective Governance and Risk Management
Effective sponsor oversight is crucial for regulatory compliance, participant safety, and data integrity in clinical trials. Zenovel offers Sponsor Oversight Services in Greece to assist sponsors in maintaining control over outsourced activities and upholding governance frameworks, ensuring compliance with EOF standards, ICH E6(R3) guidelines, EU CTR 536/2014, and international clinical research norms.
Our Sponsor Oversight Services in Greece Include:
- CRO & Vendor Oversight – Evaluation of CROs, laboratories, technology providers, and service vendors through qualification, performance monitoring, and compliance assessments.
- Clinical Governance Frameworks – Development and implementation of risk-based oversight models and governance structures.
- Site Performance Monitoring – Review of recruitment metrics, protocol compliance, data quality, operational performance, and site effectiveness.
- Quality & Compliance Oversight – Assessment of quality metrics, CAPA effectiveness, audit findings, and compliance performance.
- Risk Management & Mitigation – Identification, evaluation, and management of operational, quality, and regulatory risks.
- Regulatory Compliance Support – Alignment with EOF requirements, ICH E6(R3), EU CTR 536/2014, and applicable GCP standards.
Zenovel employs a proactive, risk-based strategy for sponsor oversight, enhancing transparency, vendor governance, trial quality, and regulatory compliance. Our expertise aids in informed decision-making and operational excellence in clinical development across Greece, Europe, and global markets.
Good Manufacturing Practice (GMP) Services in Greece for Pharmaceutical Compliance
Supporting Manufacturing Excellence Through Effective GMP Compliance
Zenovel offers GMP Services in Greece to support pharmaceutical, biotechnology, and healthcare organizations in achieving high manufacturing standards. Our services ensure product quality, patient safety, and regulatory compliance, aligning with EOF, EU-GMP, PIC/S, and WHO GMP standards.
Our GMP Services in Greece Include:
- GMP Audits & Quality System Assessments – Comprehensive evaluations of manufacturing operations and quality systems to identify compliance gaps and improvement opportunities.
- Quality Management System (QMS) Enhancement – Development, implementation, and optimization of GMP-compliant quality frameworks and procedures.
- Deviation Management & CAPA Support – Strengthening deviation investigations, root cause analysis, CAPA effectiveness, and documentation practices.
- Inspection Readiness Programs – GMP gap assessments, mock inspections, remediation planning, and regulatory inspection preparedness.
- Process Validation & GMP Consulting – Guidance on process validation, quality risk management, and sustainable GMP compliance strategies.
- Documentation & Compliance Management – Review and enhancement of SOPs, batch records, validation documents, and controlled quality records.
- Regulatory Compliance Alignment – Support for compliance with EOF requirements, EU-GMP regulations, PIC/S GMP standards, WHO GMP guidelines, and international quality expectations.
Zenovel provides organizations with practical, risk-based GMP solutions to enhance quality oversight, operational efficiency, and inspection readiness. Our multidisciplinary experts collaborate with manufacturers to create robust quality systems, minimize compliance risks, and achieve favorable regulatory outcomes in Greece, Europe, and worldwide.
GMP Audit Services for Manufacturing Quality Assurance in Greece
Strengthening Manufacturing Compliance Through Expert GMP Audits
GMP audits are crucial for maintaining product quality, patient safety, and regulatory compliance in pharmaceutical manufacturing. Zenovel offers GMP Audit Services in Greece to assist manufacturers in enhancing and upholding quality systems according to EOF requirements, EU-GMP guidelines, PIC/S GMP standards, and international best practices.
Zenovel’s GMP Audit Services in Greece Include:
- Manufacturing Process & Facility Assessments – Evaluation of production operations, facilities, utilities, equipment, and quality control systems.
- GMP Gap Analysis & CAPA Evaluation – Identification of compliance gaps and assessment of CAPA effectiveness to support continuous improvement.
- Deviation Management & QMS Reviews – Review of deviation investigations, change controls, documentation practices, and overall quality management systems.
- Inspection Readiness & Risk-Based Audits – Preparation for regulatory inspections through mock audits, compliance assessments, and risk-based audit strategies.
Zenovel’s auditors assist pharmaceutical manufacturers in recognizing compliance risks, enhancing traceability, improving quality oversight, and ensuring inspection readiness. By integrating regulatory expertise with practical audit methods, we promote sustainable GMP compliance and operational excellence in Greece, Europe, and worldwide markets.
Pharma Plant Setup & Upgradation Services in Greece for GMP Compliance
Developing GMP-Compliant Pharmaceutical Manufacturing Facilities for Sustainable Growth
Greece is becoming a key pharmaceutical manufacturing hub in Europe, backed by a skilled workforce and regulatory compliance with European standards. Establishing or upgrading facilities necessitates careful attention to engineering and quality. Zenovel offers specialized services for setting up and upgrading pharmaceutical plants, ensuring alignment with EOF requirements, EU-GMP guidelines, PIC/S standards, and global regulations.
New Pharma Plant Setup Services
- Facility Planning & Engineering Design – GMP-compliant layouts for manufacturing, warehousing, and material/personnel flow.
- Cleanroom Design & Qualification – Support for cleanroom classification, qualification, and contamination control.
- HVAC & Utility Qualification – Qualification of HVAC, water systems, compressed air, clean steam, and critical utilities.
- Equipment Qualification & Validation – IQ, OQ, and PQ support for manufacturing, packaging, laboratory, and utility equipment.
- Quality Management System (QMS) Implementation – Development of SOPs, CAPA, deviation management, and change control systems.
- Process Validation Support – Planning and execution of manufacturing process validation activities.
Existing Plant Upgradation Services
- GMP Gap Assessments & Remediation
- Facility Modernization & Infrastructure Enhancement
- Contamination Control Strategy Improvements
- Manufacturing Process Optimization
- Capacity Expansion & Technology Integration
- Quality System Strengthening & Compliance Monitoring
Zenovel provides services to ensure compliance with EOF requirements, EU-GMP, PIC/S GMP, and WHO GMP standards. This is achieved through Validation Master Plans, qualification documentation, validation protocols, and inspection readiness programs, including mock inspections.
Our team combines expertise in engineering, validation, quality, and regulations to support organizations in establishing and maintaining modern pharmaceutical manufacturing facilities, enhancing operational efficiency, product quality, and regulatory success.
Pre-Inspection Readiness Services in Greece for GMP Compliance
Strengthening Inspection Readiness Through Proactive GMP Compliance
Regulatory inspections are essential for proving GMP compliance and product quality. Zenovel offers Pre-Inspection Readiness Services in Greece, enabling pharmaceutical and biotechnology manufacturers to evaluate compliance and prepare for inspections. These services adhere to the EOF, EU-GMP guidelines, PIC/S GMP standards, and international regulatory standards.
Our Pre-Inspection Readiness Services in Greece Include:
- GMP Gap Assessments – Comprehensive reviews of manufacturing operations, facilities, and quality systems to identify compliance gaps.
- Mock Regulatory Inspections – Simulated inspections based on EU-GMP and international regulatory expectations to evaluate readiness.
- Data Integrity & CAPA Reviews – Assessment of computerized systems, audit trails, deviation management, CAPA effectiveness, and data governance practices.
- Documentation & Quality System Reviews – Evaluation of SOPs, batch records, validation documents, training records, and change control processes.
- Inspection Management & Response Planning – Development of inspection support strategies, communication plans, and response frameworks.
- Personnel Training & Inspection Coaching – Training programs focused on inspection conduct, documentation retrieval, interview preparation, and inspection-day responsibilities.
- Validation & Compliance Readiness Reviews – Assessment of equipment qualification, process validation, cleaning validation, utility systems, and computerized system validation programs.
Zenovel assists manufacturers in enhancing compliance programs and inspection readiness while mitigating regulatory risks. Through risk-based assessments and remediation strategies, our experts foster sustainable quality systems that improve operational performance and product quality and ensure long-term regulatory compliance.
Clinical & Scientific Expert Services in Greece for Drug Development Excellence
Driving Smarter Development Decisions Through Scientific and Clinical Expertise
Greece is emerging as a prime site for clinical research and healthcare innovation, backed by skilled investigators and a supportive regulatory environment. Effective product development hinges on robust scientific foundations and strategic clinical planning. Zenovel offers Clinical & Scientific Expert Services to enhance development programs and regulatory outcomes for healthcare organizations.
Our Clinical & Scientific Expert Services in Greece Include:
- Clinical Development Strategy & Protocol Design – Development of clinical plans, target product profiles, and study protocols aligned with EU and international regulatory requirements.
- Translational Medicine & PK/PD Expertise – Support for dose selection, PK/PD modeling, exposure-response analysis, and translational research strategies.
- Biomarker & Endpoint Development – Identification of biomarkers, clinical endpoints, and outcome measures that support efficient study design and evidence generation.
- Study Design Optimization – Review of patient populations, eligibility criteria, statistical approaches, and operational feasibility.
- Therapeutic Area & Medical Consulting – Expert guidance on disease landscapes, unmet needs, benefit-risk considerations, and competitive positioning.
- Regulatory Science Consulting – Strategic support for interactions with regulatory authorities, scientific advice procedures, and development planning.
- Clinical Evidence Generation – Literature reviews, real-world evidence strategies, data interpretation, and scientific communication support.
- Benefit-Risk Assessment & Decision Support – Independent scientific evaluation to support development milestones and regulatory submissions.
Zenovel leverages scientific, clinical, and regulatory expertise to assist organizations in making informed development decisions, minimizing program risks, and optimizing clinical strategies, thereby facilitating efficient development pathways and successful product advancement in European and global markets.
Medical & Scientific Writing Services in Greece for Regulatory and Clinical Documentation
Delivering High-Quality Scientific Content for Regulatory Success
Accurate medical documentation is crucial for clinical development and regulatory submissions. Zenovel offers Medical & Scientific Writing Services in Greece, assisting pharmaceutical companies, biotech firms, medical device manufacturers, CROs, and healthcare organizations. Our solutions adhere to European regulatory requirements, ICH guidelines, GCP standards, and international best practices in scientific communication.
Our Medical & Scientific Writing Services in Greece Include:
- Clinical Study Reports (CSRs), Protocols & Investigator Brochures
- Informed Consent Forms & Patient-Facing Documents
- CTD and eCTD Submission Documentation
- Pharmacovigilance & Drug Safety Reports
- Clinical Overviews, Summaries & Regulatory Documents
- Scientific Publications & Medical Communications
- Literature Reviews & Evidence Synthesis
- Medical Device & Combination Product Documentation
Zenovel provides scientifically accurate and regulatory-compliant documentation throughout the development process, including early-stage development, regulatory submissions, and post-marketing activities. Our experienced medical writers enhance document quality, ensure regulatory compliance, streamline submissions, and effectively communicate complex scientific information to various stakeholders.
Preclinical Support Services in Greece for Early-Stage Drug Development
Strengthening Drug Development Through Strategic Preclinical Expertise
A robust preclinical program is crucial for assessing the safety, efficacy, and development potential of new therapies before clinical testing, aiding in risk reduction and regulatory decision-making. Zenovel offers Preclinical Support Services in Greece to pharmaceutical companies, biotechnology firms, academic institutions, and life sciences innovators, facilitating the advancement of promising candidates from discovery to clinical readiness.
Our Preclinical Support Services in Greece Include:
- In Vitro & In Vivo Study Support – Scientific guidance for toxicology, safety pharmacology, efficacy, pharmacokinetic, pharmacodynamic, and exploratory studies.
- Bioanalytical & Translational Research Support – Integration of laboratory findings, biomarker strategies, and translational research approaches.
- Lead Candidate Evaluation & Optimization – Assessment of pharmacological profiles, safety characteristics, and development potential.
- ADME & Drug Metabolism Support – Guidance on absorption, distribution, metabolism, and excretion studies to support informed development decisions.
- Preclinical Development Strategy Consulting – Planning of nonclinical programs, study sequencing, and clinical trial readiness pathways.
- Toxicology & Safety Assessment Support – Scientific support for general toxicology, genotoxicity, reproductive toxicology, carcinogenicity, and safety pharmacology programs.
- Biomarker & Translational Science Strategy – Development of biomarker frameworks to support evidence-based clinical development.
- Regulatory Documentation Support – Preparation and review of nonclinical summaries, investigator brochures, briefing packages, and supporting regulatory documents.
Zenovel leverages scientific expertise and regulatory insight to assist organizations in generating high-quality preclinical evidence, identifying development risks early, and optimizing research strategies. Our tailored support facilitates a smoother transition from laboratory research to clinical development while ensuring compliance with European and international regulatory standards.
Regulatory Affairs & Compliance Services in Greece for Global Market Access
Enabling Faster Product Approvals Through Strategic Regulatory Expertise
In the current global regulatory landscape, effective product development and commercialization necessitate strategic regulatory planning and expert compliance support. Zenovel offers Regulatory Affairs Services in Greece for the pharmaceutical, biotechnology, medical device, and healthcare sectors, aiding in submission processes and expediting market access internationally. Our experts manage comprehensive regulatory activities in line with EOF, EMA, FDA, ICH guidelines, WHO standards, and other global authorities.
Our Regulatory Affairs & Compliance Services in Greece Include the Following:
- Regulatory Strategy Development & Gap Analysis – Tailored regulatory roadmaps, risk assessments, and submission planning strategies.
- CTD/eCTD Dossier Preparation & Management – End-to-end support for Clinical Trial Applications, MAAs, INDs, and regulatory dossiers.
- Submission Planning & Coordination – Management of timelines, dossier consistency, regulatory tracking, and cross-functional coordination.
- Labeling & Regulatory Intelligence – Development and review of labeling, packaging texts, and compliance with evolving regulatory requirements.
- Lifecycle Management & Post-Approval Support – Support for variations, renewals, line extensions, and change management activities.
- Regulatory Authority Interaction Support – Preparation for scientific advice meetings, deficiency responses, and health authority communications.
- Global Market Access Consulting – Strategic guidance for multinational registrations and cross-border regulatory harmonization.
- Compliance Monitoring & Risk Management – Identification of regulatory risks and implementation of proactive compliance strategies.
Zenovel leverages regulatory intelligence, scientific knowledge, and operational expertise to guide organizations through complex regulatory pathways. This approach facilitates compliant submissions, enhances approval timelines, and mitigates regulatory risks. Zenovel supports product registration and market access from early development to post-approval management across Greece, Europe, and global markets.
Dossier Due Diligence Services in Greece for Regulatory Submission Excellence
Strengthening Regulatory Submissions Through Expert Dossier Evaluation
High-quality regulatory dossiers are essential for timely approvals and minimizing regulatory delays. Zenovel offers Dossier Due Diligence Services in Greece, aiding pharmaceutical, biotechnology, and healthcare organizations in preparing submission-ready CTD/eCTD dossiers that meet EOF, EMA, ICH, FDA, WHO, and other global regulatory standards.
Our Dossier Due Diligence Services in Greece Include the Following:
- CTD/eCTD Gap Analysis – Identification of missing data, inconsistencies, formatting issues, and compliance gaps across submission modules.
- Clinical, Nonclinical & CMC Review – Assessment of scientific consistency, data integrity, and alignment across all technical sections of the dossier.
- Regulatory Compliance Review—Evaluation of alignment with requirements from the National Organization for Medicines (EOF) and other global health authorities.
- Cross-Module Consistency Check – Verification of coherence across clinical, nonclinical, and CMC modules to ensure unified scientific justification.
- Submission Risk Assessment – Identification of regulatory risks, scientific gaps, and potential agency queries before submission.
- Data Integrity & Traceability Review – Validation of source data traceability, study report consistency, and documentation accuracy.
- Quality & Editorial Enhancement – Improvement of clarity, structure, scientific accuracy, and regulatory alignment of dossier content.
- Regulatory Readiness Evaluation – Final assessment of submission completeness with recommendations for remediation before filing.
Zenovel employs a structured due diligence approach to help organizations identify and rectify dossier deficiencies early, thereby improving submission quality and reducing regulatory review cycles. This method increases the likelihood of successful approvals by integrating scientific expertise and regulatory intelligence, helping sponsors refine submission strategies and minimize regulatory risks in Greece, Europe, and global markets.
eCTD Compilation Services in Greece for Global Regulatory Submissions
Delivering Structured, Compliant, and Submission-Ready eCTD Dossiers
Zenovel employs a structured due diligence approach to help organizations identify and rectify dossier deficiencies early, thereby improving submission quality and reducing regulatory review cycles. This method increases the chances of successful approvals through the integration of scientific expertise and regulatory intelligence, supporting sponsors in enhancing submission strategies and minimizing regulatory risks for Greece, Europe, and global markets.
Our eCTD Compilation Services in Greece Include:
- Document Formatting & Module Organization – Structuring documents according to CTD/eCTD requirements with complete consistency across modules.
- Hyperlinking, Bookmarking & Publishing – Creation of fully navigable eCTD submissions with compliant linking and publishing standards.
- CTD to eCTD Conversion—Transformation of legacy dossiers into structured eCTD format while maintaining data integrity.
- Technical Validation & Compliance Review – Identification and correction of formatting errors, broken links, and publishing issues before submission.
- Lifecycle Management & Sequence Planning – Management of variations, renewals, responses, and post-approval submission sequences.
- Submission Quality Control – Comprehensive review of dossier completeness, technical accuracy, and regulatory alignment.
- Regulatory Publishing Support – Support for clinical trial applications, marketing authorizations, variations, and renewal submissions.
- Global Submission Strategy Support – Alignment of dossiers with multi-region regulatory requirements for streamlined approvals.
Zenovel provides high-quality eCTD compilation through regulatory intelligence, technical accuracy, and structured publishing. This method minimizes submission errors, enhances regulatory review efficiency, and ensures compliance, thereby facilitating successful submissions and quicker market access globally.
Environmental Risk Assessment (ERA) Services in Greece for Pharmaceutical Compliance and Sustainability
Ensuring healthcare solutions are not only effective but also environmentally sustainable
Environmental stewardship is vital in pharmaceutical development, necessitating Environmental Risk Assessments (ERAs) for regulatory compliance. Zenovel offers ERA services in Greece, assisting pharmaceutical and healthcare organizations in ensuring environmental compliance and promoting sustainable product development through a combination of scientific expertise and regulatory knowledge.
Our ERA Services in Greece Include:
- Phase I & Phase II Environmental Risk Assessments – Preparation and execution of ERAs for medicinal products in accordance with European regulatory requirements.
- PEC & PNEC Calculations – Estimation of Predicted Environmental Concentrations (PECs) and Predicted No-Effect Concentrations (PNECs) for environmental risk characterization.
- Ecotoxicological Data Assessment – Review and evaluation of ecotoxicity data to assess potential impacts on aquatic and terrestrial ecosystems.
- Environmental Impact & Risk Characterization – Analysis of environmental hazards, exposure scenarios, and mitigation measures to support regulatory decision-making.
- Manufacturing & Waste Management Assessments – Evaluation of waste streams, wastewater management practices, emissions controls, and sustainability initiatives.
- ERA Documentation & Regulatory Submission Support – Preparation and review of ERA reports and supporting documentation for regulatory submissions.
- Environmental Risk Mitigation Strategies – Development of practical approaches to reduce environmental impact and strengthen compliance.
Zenovel assists organizations in fulfilling environmental assessment requirements set by the EOF, EMA, and other global regulatory bodies. Our scientific approach identifies environmental risks and enhances compliance strategies while embedding sustainability in pharmaceutical development. With personalized ERA solutions, Zenovel promotes regulatory adherence, encourages responsible innovation, and supports sustainable healthcare throughout the product lifecycle.
EU QP Support Services in Greece for Batch Release and GMP Compliance
Enabling Reliable Batch Certification and Seamless European Market Access
Qualified Person (QP) certification is essential for the release of medicinal products in the European Union, ensuring compliance with GMP requirements and supporting product quality and patient safety. Zenovel offers EU QP Support Services in Greece, assisting pharmaceutical manufacturers, biotechnology firms, and CMOs in optimizing batch release activities and enhancing GMP compliance throughout the supply chain.
Our EU QP Support Services in Greece Include:
- Batch Record Review & GMP Compliance Verification – Assessment of manufacturing, packaging, and quality control records is essential for making informed batch release decisions.
- Deviation & Quality Impact Assessment – Review focuses on deviations, investigations, out-of-specification (OOS) results, change controls, and corrective and preventive actions (CAPA) that impact batch disposition.
- QP Coordination & Certification Support – Facilitation of documentation review, quality evaluations, and QP certification workflows.
- Quality Documentation Review – Evaluation of Certificates of Analysis, validation reports, stability data, environmental monitoring records, and supplier qualifications.
- Regulatory Compliance Verification – Evaluation of compliance with EU GMP Guidelines, Annex 16 requirements, PIC/S GMP standards, and other applicable regulations.
- Supply Chain & Manufacturing Oversight – Review of manufacturing controls, traceability systems, and supplier quality management processes.
- Inspection Readiness & Quality Assurance – Support through GMP assessments, documentation reviews, mock audits, and compliance evaluations.
- Lifecycle Quality Support – Support with ongoing quality oversight, risk management, post-approval compliance, and continuous improvement initiatives.
Zenovel’s GMP and regulatory experts assist organizations in creating compliant and efficient batch release processes, thereby reducing certification delays and minimizing regulatory risks. By adhering to EU GMP, Annex 16, PIC/S standards, and best practices, Zenovel enhances product quality and helps ensure regulatory compliance for access to European and global markets.
Regulatory Gap Analysis Services in Greece for Compliance Readiness and Regulatory Excellence
Strengthening Compliance Through Proactive Regulatory Assessments
Zenovel offers Regulatory Gap Analysis Services in Greece for pharmaceutical, biotechnology, medical device, and healthcare organizations. Our services help identify compliance gaps before they result in regulatory findings, thereby enhancing operational efficiency and product development. Experts at Zenovel perform thorough assessments of quality systems, regulatory documentation, operational processes, and compliance programs to identify risks and foster sustainable improvements.
Our Regulatory Gap Analysis Services in Greece Include the Following:
- Dossier Completeness & Data Integrity Reviews – Evaluation of clinical, nonclinical, and CMC documentation focuses on ensuring consistency, traceability, and regulatory compliance.
- SOP & Quality Management System Assessments – Review of QMS frameworks, including SOPs, CAPA programs, and processes for deviation management, change control, and governance.
- Regulatory Submission Readiness Evaluations – Estimation of dossiers and supporting documentation before submission to EOF, EMA, and other health authorities.
- Gap Identification & Compliance Risk Assessment – Identification of documentation deficiencies, process vulnerabilities, compliance risks, and operational gaps.
- Clinical Research Compliance Reviews – Evaluation of clinical trial processes, sponsor oversight, monitoring activities, and GCP compliance.
- Manufacturing & GMP Compliance Assessments – Review of GMP systems, validation programs, quality controls, data integrity practices, and inspection readiness.
- Regulatory Intelligence & Benchmarking – Comparison of current practices against evolving regulatory expectations and industry best practices.
- Remediation Strategy & CAPA Planning – Development of risk-based remediation plans, corrective actions, and continuous improvement roadmaps.
Zenovel’s structured gap analysis methodology helps organizations identify compliance weaknesses and enhance quality systems for improved regulatory performance. By aligning with EOF requirements, EMA expectations, EU regulations, ICH guidelines, and international quality standards, it provides practical recommendations for inspection readiness and long-term compliance, facilitating sustainable growth and regulatory success.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
